Search for: "Shire Pharmaceutical Development Inc" Results 1 - 20 of 34
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Feb 2017, 9:13 pm by Patent Docs
The lawsuit involved Watson's ANDA filing seeking approval for a generic version of Shire's controlled-release oral pharmaceutical composition for the treatment of inflammatory bowel disease, Crohn's disease, and ulcerative colitis, sold by Shire under the brand name LIALDA®. [read post]
28 Jan 2015, 10:00 pm by Courtenay C. Brinckerhoff
On January 26, 2015, the Supreme Court granted certiorari, vacated, and remanded Shire Development LLC v. [read post]
18 Dec 2011, 3:45 pm by Patent Docs
Mylan Pharmaceuticals Inc. et al. 1:11-cv-00201; filed December 15, 2011 in the Northern District of West Virginia • Plaintiffs: Shire LLC; Supernus Pharmaceuticals, Inc.; Shire Development Inc.; Shire International Licensing B. [read post]
11 Jul 2010, 9:52 pm by Patent Docs
Shire Development Inc. et al. v. [read post]
15 Jan 2012, 8:27 pm by Patent Docs
Sandoz Inc. 1:12-cv-00040; filed January 6, 2012 in the District Court of Colorado • Plaintiffs: Shire LLC; Supernus Pharmaceuticals, Inc.; Shire Development Inc.; Shire International Licensing B.V.; Amy F.T. [read post]
24 Nov 2013, 9:04 pm by Patent Docs
Apotex Corp. et al. 1:13-cv-24236; filed November 21, 2013 in the Southern District of Florida • Plaintiffs: Shire LLC; Shire Development LLC; Supernus Pharmaceuticals, Inc. [read post]
17 Aug 2009, 8:01 am
As a result, the giant generic pharmaceutical concern has become the utmost patent copycat pharmaceutical player on the international scene. [read post]
17 Aug 2009, 8:01 am
As a result, the giant generic pharmaceutical concern has become the utmost patent copycat pharmaceutical player on the international scene. [read post]
4 Jun 2012, 9:55 pm by Patent Docs
Shire Development, LLC et al. v. [read post]
1 Dec 2017, 11:35 am by Nate Nead
Bard in Q2 2017 helped increase the value of deals.[27] Takeda Pharmaceutical Company acquired ARIAD Pharmaceuticals Inc for $5.2 billion to expand its oncology business. [read post]
31 Jul 2014, 12:00 am
Rosenzweig During the past year, major corporations, including Chiquita Brands International Inc., Mallinckrodt Pharmaceuticals, Abbvie Inc., Applied Materials Inc., and Medtronic Inc., have announced or completed such deals. [read post]
12 Sep 2011, 6:18 am
Travis Mickle, President of KemPharm, Inc., a small early-phase biopharmaceutical company, was working as a senior research scientist for Lotus Biochemical Corporation (which became New River Pharmaceuticals ("NRP")) in 2001. [read post]